Based on the data provided, Genpact Ltd (G) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, hedge funds are selling, and there are no significant positive trading signals or catalysts to suggest immediate upside potential. While the company has shown modest financial growth and maintains a strong ethical reputation, the lack of strong momentum and mixed analyst ratings suggest holding off on a purchase for now.
The technical indicators for Genpact Ltd are bearish. The MACD is negative and expanding downward, RSI is neutral but leaning toward oversold territory, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 38.135, with key support at 37.153 and resistance at 39.116.

Genpact has been recognized as one of the World's Most Ethical Companies, highlighting its excellence in corporate governance and ESG initiatives. The Advanced Technology Solutions segment continues to show momentum, driving growth in the latest quarter.
Hedge funds are selling the stock, with a significant increase in selling activity (805.73% over the last quarter). Technical indicators are bearish, and the stock is expected to decline further in the short term. Analysts have lowered price targets, with mixed ratings ranging from Neutral to Buy.
In Q4 2025, Genpact reported revenue growth of 5.65% YoY, net income growth of 0.83% YoY, EPS growth of 3.80% YoY, and gross margin improvement of 2.33% YoY. While these are positive, the growth rates are modest and do not indicate a strong upward trajectory.
Analysts have mixed views on Genpact. Needham maintains a Buy rating but lowered the price target to $50 from $53. Susquehanna has a Neutral rating and lowered the price target to $42 from $50, citing solid execution but concerns about slower growth in the core business.